Name:
Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate)
Type:
Stimulant
AKA:
N/A
Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) image
Synthetic substance, no natural derivative
IUPAC Logo
Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) image
Mesocarb, a stimulant, was developed in the 1960s. It was used primarily in the former Soviet Union as a treatment for attention and mood disorders. Its history includes its use in sports and its eventual decline due to regulatory changes and the development of new stimulants.
Synthetic Substances Image
Mesocarb is a stimulant that increases energy, alertness, and euphoria. It causes dilated pupils, elevated heart rate, and increased blood pressure. Short-term effects include enhanced cognitive and physical performance, while long-term use may lead to cardiovascular issues and psychological dependence. Overdose risks include severe agitation and cardiovascular problems. Safe dosing is critical, and recent research focuses on its stimulant properties and potential for abuse.
N/A
Mesocarb, a stimulant, affects dopamine and norepinephrine systems, leading to increased alertness and mood enhancement. Immediate effects include improved mood and energy, lasting several hours. Long-term use may result in cognitive impairments and mood disturbances. Research highlights its stimulant effects and associated risks of psychological dependence.
N/A
Mesocarb is a stimulant used for its cognitive-enhancing and wakefulness-promoting effects. It has been used in various contexts, including military applications and as a treatment for attention deficit disorders. The history of stimulants includes their use for enhancing cognitive and physical performance, as well as their potential for misuse and addiction. Mesocarb's cultural significance lies in its representation of the broader interest in nootropics and performance-enhancing drugs. Media coverage often focuses on the benefits and risks of such substances, contributing to discussions about cognitive enhancement, mental health, and the ethics of using stimulants for non-medical purposes.
N/A